Vaxart is a company that manufactures vaccines that are consumed by ingesting medicine pills using an independent delivery platform. Vaxart’s vaccine can be transported without cooling in special containers. The shares of the biotech company have been growing for 4 consecutive days. During this period, the price increased by 16%. Investors hope that this will continue. In a pre-market session, the stock is trading at $7.89. Will the company be able to keep this pace until the end of the year to break its record for the highest price of $11.98 for 2021?
Vaxart, Inc. announced that the company’s vice president, Sean Tucker, will attend and speak at the World Vaccine & Immunotherapy Congress West Coast 2021, which will be held tomorrow. It’s part of an award-winning series of conferences and exhibitions that’s steadily rising to become the world’s largest and most established vaccination events. Vaxart’s CSO will discuss the company’s research program for an oral candidate for the COVID-19 vaccine in the form of tablets. The medicine that needs to be swallowed against coronavirus is the only oral vaccine of its kind against COVID-19, which has immunological potential, which is confirmed. And this is only one vaccine that has been conducting Phase 2 clinical trials since October 2021.